ArticleThe Lancet regional health. Southeast Asia2026
Immunogenicity and safety of high-dose versus double-dose quadrivalent inactivated influenza vaccine in adult kidney transplant recipients: a randomized controlled trial (2023).
Thanachote Arayanumas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.